TruBridge, Inc. Hits New 52-Week Low at $17.75

TruBridge, Inc., a microcap company in the healthcare services industry, has recently reached a new 52-week low of USD 17.75 on March 10, 2026. This significant drop highlights the stock's volatility, especially considering its previous high of USD 32 within the same year. Despite this recent decline, TruBridge has demonstrated a remarkable one-year performance of 84.94%, significantly outperforming the S&P 500, which recorded a 20.78% increase over the same period. The company's market capitalization stands at USD 306 million, reflecting its position as a microcap entity in the healthcare sector. Financially, TruBridge is currently loss-making, with a price-to-earnings ratio that is not applicable. The company has a debt-to-equity ratio of 0.81, indicating a moderate level of debt relative to its equity. Additionally, TruBridge's return on equity is reported at 6.15%, and it has a price-to-book ratio of 1.70. As the stock navigates these fluctuations, its performance metrics will be closely monitored by market participants.